These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 24621955)

  • 1. Induction of pluripotency by defined factors.
    Tanabe K; Takahashi K; Yamanaka S
    Proc Jpn Acad Ser B Phys Biol Sci; 2014; 90(3):83-96. PubMed ID: 24621955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Present and future challenges of induced pluripotent stem cells.
    Ohnuki M; Takahashi K
    Philos Trans R Soc Lond B Biol Sci; 2015 Oct; 370(1680):20140367. PubMed ID: 26416678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retention of Somatic Memory Associated with Cell Identity, Age and Metabolism in Induced Pluripotent Stem (iPS) Cells Reprogramming.
    Khoo TS; Jamal R; Abdul Ghani NA; Alauddin H; Hussin NH; Abdul Murad NA
    Stem Cell Rev Rep; 2020 Apr; 16(2):251-261. PubMed ID: 32016780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular reprogramming: a small molecule perspective.
    Nie B; Wang H; Laurent T; Ding S
    Curr Opin Cell Biol; 2012 Dec; 24(6):784-92. PubMed ID: 22959962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Derivation of novel human ground state naive pluripotent stem cells.
    Gafni O; Weinberger L; Mansour AA; Manor YS; Chomsky E; Ben-Yosef D; Kalma Y; Viukov S; Maza I; Zviran A; Rais Y; Shipony Z; Mukamel Z; Krupalnik V; Zerbib M; Geula S; Caspi I; Schneir D; Shwartz T; Gilad S; Amann-Zalcenstein D; Benjamin S; Amit I; Tanay A; Massarwa R; Novershtern N; Hanna JH
    Nature; 2013 Dec; 504(7479):282-6. PubMed ID: 24172903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced pluripotent stem (iPS) cells: a new source for cell-based therapeutics?
    de Lázaro I; Yilmazer A; Kostarelos K
    J Control Release; 2014 Jul; 185():37-44. PubMed ID: 24746625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic insights into reprogramming to induced pluripotency.
    Ho R; Chronis C; Plath K
    J Cell Physiol; 2011 Apr; 226(4):868-78. PubMed ID: 20945378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reprogramming in vivo produces teratomas and iPS cells with totipotency features.
    Abad M; Mosteiro L; Pantoja C; Cañamero M; Rayon T; Ors I; Graña O; Megías D; Domínguez O; Martínez D; Manzanares M; Ortega S; Serrano M
    Nature; 2013 Oct; 502(7471):340-5. PubMed ID: 24025773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trib2 regulates the pluripotency of embryonic stem cells and enhances reprogramming efficiency.
    Do EK; Park JK; Cheon HC; Kwon YW; Heo SC; Choi EJ; Seo JK; Jang IH; Lee SC; Kim JH
    Exp Mol Med; 2017 Nov; 49(11):e401. PubMed ID: 29170476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plant hormones increase efficiency of reprogramming mouse somatic cells to induced pluripotent stem cells and reduce tumorigenicity.
    Alvarez Palomo AB; McLenachan S; Requena Osete J; Menchón C; Barrot C; Chen F; Munné-Bosch S; Edel MJ
    Stem Cells Dev; 2014 Mar; 23(6):586-93. PubMed ID: 24251409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromatin structure of pluripotent stem cells and induced pluripotent stem cells.
    Delgado-Olguín P; Recillas-Targa F
    Brief Funct Genomics; 2011 Jan; 10(1):37-49. PubMed ID: 21325400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linking incomplete reprogramming to the improved pluripotency of murine embryonal carcinoma cell-derived pluripotent stem cells.
    Chang G; Miao YL; Zhang Y; Liu S; Kou Z; Ding J; Chen DY; Sun QY; Gao S
    PLoS One; 2010 Apr; 5(4):e10320. PubMed ID: 20436676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospects of induced pluripotent stem cell technology in regenerative medicine.
    Zhang F; Citra F; Wang DA
    Tissue Eng Part B Rev; 2011 Apr; 17(2):115-24. PubMed ID: 21210760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemically Induced Reprogramming of Somatic Cells to Pluripotent Stem Cells and Neural Cells.
    Biswas D; Jiang P
    Int J Mol Sci; 2016 Feb; 17(2):226. PubMed ID: 26861316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomaterial aided differentiation and maturation of induced pluripotent stem cells.
    Velmurugan BK; Bharathi Priya L; Poornima P; Lee LJ; Baskaran R
    J Cell Physiol; 2019 Jun; 234(6):8443-8454. PubMed ID: 30565686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new era of disease modeling and drug discovery using induced pluripotent stem cells.
    Suh W
    Arch Pharm Res; 2017 Jan; 40(1):1-12. PubMed ID: 27921262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vivo Cellular Reprogramming: The Next Generation.
    Srivastava D; DeWitt N
    Cell; 2016 Sep; 166(6):1386-1396. PubMed ID: 27610565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentialities of induced pluripotent stem (iPS) cells for treatment of diseases.
    Chakraborty C; Shah KD; Cao WG; Hsu CH; Wen ZH; Lin CS
    Curr Mol Med; 2010 Nov; 10(8):756-62. PubMed ID: 20937020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in Genetic Reprogramming: Prospects from Developmental Biology to Regenerative Medicine.
    Dhanjal DS; Singh R; Sharma V; Nepovimova E; Adam V; Kuca K; Chopra C
    Curr Med Chem; 2024; 31(13):1646-1690. PubMed ID: 37138422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced pluripotent stem cells for regenerative medicine.
    Hirschi KK; Li S; Roy K
    Annu Rev Biomed Eng; 2014 Jul; 16():277-94. PubMed ID: 24905879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.